Concepedia

Biomarker Verification

Biomarker Verification is a methodological process in translational research that confirms the analytical performance and reproducibility of a biomarker assay under defined conditions, distinguishing it from biomarker discovery or validation by focusing on the technical accuracy and consistency of biomarker measurement.

89

Publications

5.9K

Citations

680

Authors

302

Institutions

Publications per year

2017–2026

25

Parents

Publications

89

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

Jean W. Lee, Viswanath Devanarayan, Yu Chen Barrett et al. · Pharmaceutical Research · 2006 · 759 citations

, , +11

Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

Elisabeth Drucker, Kurt Krapfenbauer · The EPMA Journal · 2013 · 348 citations · Full text

, , +17

Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution

Hasmik Keshishian, Terri A. Addona, Michael Burgess et al. · Molecular & Cellular Proteomics · 2009 · 284 citations · Full text

, , +17

Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics

Ruth Hüttenhain, Martin Soste, Nathalie Selevsek et al. · Science Translational Medicine · 2012 · 247 citations

, , +17

Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry

Eric Kuhn, Terri A. Addona, Hasmik Keshishian et al. · Clinical Chemistry · 2009 · 247 citations · Full text

, , +17

1–5 of 89

Authors

680

  1. FG
    Federico Goodsaid

    Center for Drug Evaluation and Research, United States

    3 publications · 230 citations

    3

    h-index

  2. EK
    Eric Kuhn

    Broad Institute, United States

    3 publications · 568 citations

    3

    h-index

  3. HK
    Hasmik Keshishian

    Broad Institute, United States

    3 publications · 568 citations

    3

    h-index

  4. SA
    Steven A. Carr

    Broad Institute, United States

    3 publications · 568 citations

    3

    h-index

  5. RI
    Rafiq Islam

    Pharmaceutical Product Development (United States), United States

    3 publications · 123 citations

    3

    h-index

1–5 of 680

Institutions

302

  1. Amgen (United States)

    Thousand Oaks, United States

    5 h-index

    10 publications

    375 citations

  2. Pfizer (United States)

    New York, United States

    5 h-index

    11 publications

    2.8K citations

  3. United States Food and Drug Administration

    Silver Spring, United States

    5 h-index

    7 publications

    548 citations

  4. Center for Drug Evaluation and Research

    Silver Spring, United States

    4 h-index

    10 publications

    492 citations

  5. AbbVie (United States)

    North Chicago, United States

    4 h-index

    12 publications

    1.2K citations

  6. Bristol-Myers Squibb (United States)

    New York, United States

    3 h-index

    7 publications

    2K citations

  7. Eli Lilly (United States)

    Indianapolis, United States

    3 h-index

    5 publications

    1.2K citations

  8. Pharmaceutical Product Development (United States)

    Wilmington, United States

    3 h-index

    9 publications

    288 citations

1–8 of 302

Venues

  1. Bioanalysis

    BIO · 7 publications · 228 citations

    7

    h-index

  2. Journal of Proteome Research

    JPR · 6 publications · 356 citations

    6

    h-index

  3. PLoS ONE

    3 publications · 84 citations

    3

    h-index

  4. PROTEOMICS - CLINICAL APPLICATIONS

    3 publications · 261 citations

    3

    h-index

  5. Methods

    2 publications · 120 citations

    2

    h-index

1–5